Search research articles
Contact Us
Filters
Showing results (391-400 of 434) with videos related to
Page
of 44
Sort By:
Journal of the American Academy of Dermatology
|
November 19, 2025
Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors
Andrew Blauvelt, Bruce E Strober, Guy S Eakin, et al.
The Journal of Rheumatology
|
February 16, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting
Carmel Stober, Deepak R Jadon, April W Armstrong, et al.
JAMA Dermatology
|
November 27, 2024
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials
April W Armstrong, Mark Lebwohl, Richard B Warren, et al.
The New England Journal of Medicine
|
December 8, 2021
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis
Mark G Lebwohl, Linda Stein Gold, Bruce Strober, et al.
The British Journal of Dermatology
|
August 28, 2025
SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site Involvement
Linda Stein Gold, Alice B Gottlieb, April W Armstrong, et al.
Acta Dermato-Venereologica
|
June 11, 2026
Efficacy and Safety of Nemolizumab at Week 48: Results from the Maintenance Phase of Two Global Phase 3 Pivotal Studies (ARCADIA 1&2) in Patients with Moderate-to-Severe Atopic Dermatitis
Andreas Wollenberg, Jonathan I Silverberg, Franz J Legat, et al.
The Journal of Rheumatology
|
April 2, 2022
Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting
Carmel Stober, Iain B McInnes, Soumya Raychaudhuri, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
March 5, 2019
Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease
James A Solomon, Michael Oswalt, Michael Nodzenski, et al.
Allergy
|
December 18, 2023
Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis
Emma Guttman-Yassky, Paola Facheris, Pedro Jesus Gomez-Arias, et al.
Journal of the American Academy of Dermatology
|
July 26, 2023
Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasis registry
Joy Q Jin, Angel Cronin, Carla Roberts-Toler, et al.
Page
of 44
Search research articles
Search
Showing results (391-400 of 434) with videos related to
Sort By:
Page
of 44
Journal of the American Academy of Dermatology
|
November 19, 2025
Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors
Andrew Blauvelt, Bruce E Strober, Guy S Eakin, et al.
The Journal of Rheumatology
|
February 16, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting
Carmel Stober, Deepak R Jadon, April W Armstrong, et al.
JAMA Dermatology
|
November 27, 2024
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials
April W Armstrong, Mark Lebwohl, Richard B Warren, et al.
The New England Journal of Medicine
|
December 8, 2021
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis
Mark G Lebwohl, Linda Stein Gold, Bruce Strober, et al.
The British Journal of Dermatology
|
August 28, 2025
SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site Involvement
Linda Stein Gold, Alice B Gottlieb, April W Armstrong, et al.
Acta Dermato-Venereologica
|
June 11, 2026
Efficacy and Safety of Nemolizumab at Week 48: Results from the Maintenance Phase of Two Global Phase 3 Pivotal Studies (ARCADIA 1&2) in Patients with Moderate-to-Severe Atopic Dermatitis
Andreas Wollenberg, Jonathan I Silverberg, Franz J Legat, et al.
The Journal of Rheumatology
|
April 2, 2022
Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting
Carmel Stober, Iain B McInnes, Soumya Raychaudhuri, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
March 5, 2019
Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease
James A Solomon, Michael Oswalt, Michael Nodzenski, et al.
Allergy
|
December 18, 2023
Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis
Emma Guttman-Yassky, Paola Facheris, Pedro Jesus Gomez-Arias, et al.
Journal of the American Academy of Dermatology
|
July 26, 2023
Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasis registry
Joy Q Jin, Angel Cronin, Carla Roberts-Toler, et al.
Page
of 44